State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium
Conclusions
There is a need for international guidelines regarding the appropriate timing and selection of imaging modality for patients with CF lung disease; timing and selection depends upon the clinical scenario, the patient's age, lung function and type of treatment. Despite its ubiquity, the use of the chest radiograph remains controversial. Both computed tomography and magnetic resonance imaging should be routinely used to monitor CF lung disease. Future studies should focus on imaging protocol harmonisation both for computed tomography and for magnetic resonance imaging. The introduction of artificial intelligence imaging analysis may further revolutionise clinical practice by providing fast and reliable quantitative outcomes to assess disease status. To date, there is no evidence supporting the use of lung ultrasound to monitor CF lung disease.
Source: European Respiratory Review - Category: Respiratory Medicine Authors: Ciet, P., Bertolo, S., Ros, M., Casciaro, R., Cipolli, M., Colagrande, S., Costa, S., Galici, V., Gramegna, A., Lanza, C., Lucca, F., Macconi, L., Majo, F., Paciaroni, A., Parisi, G. F., Rizzo, F., Salamone, I., Santangelo, T., Scudeller, L., Saba, L., To Tags: Lung imaging, CF and non-CF bronchiectasis Review Source Type: research
More News: Conferences | CT Scan | Cystic Fibrosis | Italy Health | Lung Transplant | MRI Scan | Radiography | Radiology | Respiratory Medicine | Study | Ultrasound